Cargando…

Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects

Histone acetylation and deacetylation play important roles in the regulation of gene transcription and in the modulation of chromatin structure. The levels of histone acetylation are determined by the activities of histone acetyltransferases and histone deacetylases (HDACs). HDACs are associated wit...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sato, Akinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346061/ https://www.ncbi.nlm.nih.gov/pubmed/22573938 http://dx.doi.org/10.2147/OTT.S23874

Ejemplares similares

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
por: Duvic, Madeleine, et al.
Publicado: (2007)

Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma
por: Duvic, M, et al.
Publicado: (2006)

Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
por: Okubo, Kazuki, et al.
Publicado: (2019)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
por: Gao, Minjie, et al.
Publicado: (2016)

Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020)

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
por: Hagihara, Mao, et al.
Publicado: (2012)

Romidepsin in the treatment of cutaneous T-cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2011)

Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78
por: Fujii, Kazuyasu, et al.
Publicado: (2021)

Differential Response of Mycosis Fungoides Cells to Vorinostat
por: Bordeaux, Zachary A., et al.
Publicado: (2023)

Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
por: Bergadà, Laura, et al.
Publicado: (2014)

Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells
por: Ma, Xiaoli, et al.
Publicado: (2017)

Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments
por: Ghashghaei, Shahriar, et al.
Publicado: (2023)

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008)

Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
por: Pelcovits, Ari, et al.
Publicado: (2023)

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2014)

Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan
por: Takahashi, Yuka, et al.
Publicado: (2014)

Clinical Efficacy of Vorinostat in a Patient with Leiomyosarcoma
por: Lee, Jin, et al.
Publicado: (2012)

The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
por: O'Connor, O A
Publicado: (2006)

An overview of cutaneous T cell lymphomas
por: Bagherani, Nooshin, et al.
Publicado: (2016)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
por: Mori, Masaaki, et al.
Publicado: (2008)

Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells
por: Liao, Bo, et al.
Publicado: (2017)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Primary cutaneous lymphomas: diagnosis and treatment
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2015)

Cutaneous primary B-cell lymphomas: from diagnosis to treatment
por: Lima, Margarida
Publicado: (2015)

Cutaneous T-Cell Lymphoma in Asians
por: Jang, Min Soo, et al.
Publicado: (2012)

Cutaneous Lymphomas in India: Prospects and Limitations
por: Raychaudhury, Tanumay
Publicado: (2017)

Photodynamic Therapy as an Effective Treatment for Cutaneous Lymphomas
por: Caccavale, Stefano, et al.
Publicado: (2022)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)

The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
por: Chao, Min-Wu, et al.
Publicado: (2015)

Direct but No Transgenerational Effects of Decitabine and Vorinostat on Male Fertility
por: Kläver, Ruth, et al.
Publicado: (2015)

Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy
por: Zierfuss, Bettina, et al.
Publicado: (2020)

Methotrexate/tacrolimus/vorinostat: Lack of efficacy: case report
Publicado: (2022)

New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
por: Stancu, Andreea Lucia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r6bpofksr7bugq8h01tj89i25u